Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN vs LUTETIUM OXODOTREOTIDE LU-177: Safety Overview

Metric LUTETIUM LU-177 VIPIVOTIDE TETRAXETAN LUTETIUM OXODOTREOTIDE LU-177
Total FAERS Reports 10,716 5,311
Deaths Reported 1,461 691
Death Rate 13.6% 13.0%
Hospitalizations 545 635
Average Patient Age 72.9 yrs 62.6 yrs
% Female Patients 0.7% 49.2%
FDA Approval Date Mar 23, 2022 N/A
Manufacturer Novartis Pharmaceuticals Corporation Advanced Accelerator Applications USA...
Route INTRAVENOUS INTRAVENOUS
Marketing Status Prescription N/A